[Diagnosis and therapy for polymyalgia rheumatica].
Sano
Hajime
H
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D013700:Giant Cell Arteritis / Q000150:complications / Q000175:diagnosis; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D000069285:Infliximab; D011111:Polymyalgia Rheumatica / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D012017:Referral and Consultation
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D002097:C-Reactive Protein; D011239:Prednisolone; D000069285:Infliximab